CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...

Microsoft is working on a redesigned Run dialog for Windows 11, but Raycast has just beaten the company with a much better ...

Win streak rewards have arrived in Warzone with Season 1 Reloaded, so here’s every camo and how you can unlock each one.

Japanese cybersecurity software firm Trend Micro has patched a critical security flaw in Apex Central (on-premise) that could allow attackers to execute arbitrary code with SYSTEM privileges.

ATLANTA — A former executive with the Atlanta Housing Authority is accused of orchestrating an elaborate scheme that federal prosecutors say siphoned more than $200,000 in government funds for ...

Donald Trump mocked after seemingly confusing bald eagle with a falcon Hugh Jackman and Kate Hudson face backlash from real family behind tribute band film The Trump administration just ordered ...

Video game developer Vince Zampella, whose studios have created several of the world's best-selling games, was killed Sunday afternoon in a Ferrari crash on Southern California's Angeles Crest Highway ...

Vince Zampella, best known as the co-creator of the Call of Duty franchise and co-founder of Infinity Ward who went on to co-found Titanfall, Apex Legends, and Star Wars Jedi developer Respawn ...

Ex-Astronomer HR exec Kristin Cabot slammed “hypocrite” Gwyneth Paltrow for poking fun at her viral Coldplay kiss cam scandal. “I was such a fan of her company [Goop], which seemed to be about ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...